Bellaterra, Spain

Anna Roig Serra

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Anna Roig Serra

Introduction

Anna Roig Serra is a notable inventor based in Bellaterra, Spain. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antifungal compounds. With a total of two patents to her name, her work is recognized for its potential impact on treating various microbial and fungal infections.

Latest Patents

Anna Roig Serra's latest patents focus on crystalline antifungal compounds. These patents describe novel crystalline forms of (1R,2R)-7-chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one. The patents detail pharmaceutical compositions containing these crystalline forms, methods for using them to treat and prevent infections, and processes for obtaining these forms. Specifically, the patents highlight crystalline Forms I, II, III, IV, V, and VI of the compound, showcasing her innovative approach to addressing health challenges.

Career Highlights

Throughout her career, Anna has worked with reputable companies such as Palau Pharma and Stiefel Laboratories, Inc. Her experience in these organizations has contributed to her expertise in pharmaceutical development and innovation.

Collaborations

Anna has collaborated with notable colleagues, including Antonio Cánovas Paredes and Javier Bartroli Orpi. These partnerships have likely enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Anna Roig Serra's contributions to the field of antifungal compounds demonstrate her commitment to innovation in pharmaceutical sciences. Her patents reflect a significant advancement in the treatment of microbial and fungal infections, showcasing her role as a leading inventor in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…